Skip to main content
Log in

Nabumetone

Evidence for the Lack of Enterohepatic Circulation of the Active Metabolite 6-MNA in Humans

  • Section 2: Symposium on NSAIDs
  • Short Communication
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Boyle EA, Freeman PC, Mangan FR, Thomson MJ. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one); a new anti-inflammatory agent. Journal of Pharmacy and Pharmacology 34: 562–569, 1982

    Article  PubMed  CAS  Google Scholar 

  • Haddock RE, Jeffrey DJ, Lloyd JA, Thawley AR. Metabolism of nabumetone (BRL 14777) by various species including man. Xenobiotica 14: 327–337, 1984

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brett, M.A., Buscher, G., Ellrich, E. et al. Nabumetone. Med Toxicol Adverse Drug Exp 40 (Suppl 5), 67–70 (1990). https://doi.org/10.2165/00003495-199000405-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199000405-00017

Keywords

Navigation